Seres Therapeutics
MCRB
MCRB
69 hedge funds and large institutions have $52.5M invested in Seres Therapeutics in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 16 closing their positions.
Holders
69
Holders Change
-7
Holders Change %
-9.21%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
9
Increased
18
Reduced
18
Closed
16
Calls
$2.76M
Puts
$287K
Net Calls
+$2.47M
Net Calls Change
+$1.87M
Top Buyers
1 |
1
Morgan Stanley
New York
|
$1.67M |
2 |
2
Millennium Management
New York
|
$1.5M |
3 |
3
Vontobel Holding
Zurich,
Switzerland
|
$780K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$284K |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$1.26M |